 CAMBRIDGE, Mass.--BUSINESS WIRE--Sage Therapeutics NASDAQ: SAGE, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced the appointment of Chris Benecchi as Chief Commercial Officer. In his new role, Mr. Benecchi will lead Sages global commercial efforts across all Sage programs, new product planning, strategy, and competitive intelligence. Chris Benecchi is an innova 